Changes in standard of care (SOC) medication during long-term mavacamten treatment for obstructive hypertrophic cardiomyopathy (HCM): results from the EXPLORER cohort of MAVA-Long-Term Extension (LTE) Lakdawala, N., Afshar, K., Barriales-Villa, R., Gimeno-Blanes, J., Michels, M., Saberi, S., Wheeler, M. T., Balaratnam, G., Shah, A., Chen, Y. M., Sehnert, A. J., Abraham, T. P. OXFORD UNIV PRESS. 2023

View details for Web of Science ID 001115619403092